KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Shares Outstanding: 2009-2023

Historic Shares Outstanding for Neogenomics (NEO) over the last 5 years, with Jun 2023 value amounting to $127.1 million.

  • Neogenomics' Shares Outstanding rose 1.17% to $127.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $127.1 million, marking a year-over-year increase of 1.17%. This contributed to the annual value of $126.9 million for FY2022, which is 2.26% up from last year.
  • Per Neogenomics' latest filing, its Shares Outstanding stood at $127.1 million for Q2 2023, which was down 0.04% from $127.2 million recorded in Q1 2023.
  • Over the past 5 years, Neogenomics' Shares Outstanding peaked at $127.2 million during Q1 2023, and registered a low of $95.3 million during Q1 2019.
  • Its 3-year average for Shares Outstanding is $124.5 million, with a median of $125.2 million in 2022.
  • Data for Neogenomics' Shares Outstanding shows a peak YoY grew of 27.41% (in 2019) over the last 5 years.
  • Quarterly analysis of 5 years shows Neogenomics' Shares Outstanding stood at $104.8 million in 2019, then rose by 6.96% to $112.1 million in 2020, then climbed by 10.74% to $124.1 million in 2021, then climbed by 2.26% to $126.9 million in 2022, then climbed by 1.17% to $127.1 million in 2023.
  • Its last three reported values are $127.1 million in Q2 2023, $127.2 million for Q1 2023, and $126.9 million during Q4 2022.